ArticleOncology letters2015

Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate.

Juan Sepulveda-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.